Shares in Glaukos (NYSE:GKOS) fell -10% today after the ophthalmic medtech company beat expectations on Wall Street with its 1st quarter results.
The San Clemente, Calif.-based company posted profits of $878,000, or 2¢ per share, on sales of $35.9 million for the 3 months ended March 31, for bottom-line loss of -2% on sales growth of 55% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Glaukos shares tumble despite Q1 beat appeared first on MassDevice.
from MassDevice http://ift.tt/2p0ZLKw
Cap comentari:
Publica un comentari a l'entrada